Biotech Is Difficult Till The Election - Cramer's Lightning Round

Biotech Is Difficult Till The Election - Cramer's Lightning Round


Celgene : The company reports next week. Cramer thinks the company is not involved in price gouging, but he advised staying away until the election is over.



from Biotech News